No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Africa is grappling with severe food insecurity in the wake of consecutive droughts, climate change, and ongoing conflicts, which are affecting millions across the continent.

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant access to gene-editing therapy on the NHS.

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

Doudna spoke about all the new opportunities created by the development of the gene-editing tool CRISPR-Cas9. In March last year, Nice rejected Casgevy for people with severe sickle cell disease.

Emmanuelle Charpentier and Jennifer Doudna leveraged CRISPR into a pair ... Since Emmanuelle and Jennifer published their 2012 paper on CRISPR/Cas9, researchers have used these genetic scissors ...

Scribe Therapeutics, a start-up focusing on gene-editing using CRISPR/Cas9, has burst onto the biotech scene with a $415 million deal with Biogen. Scribe – which counts new Nobel Prize for ...

chemistry laureate Jennifer Doudna In her 2020 Nobel Prize lecture, Doudna spoke about all the new opportunities created by the development of the gene-editing tool CRISPR-Cas9. At the time Nice said ...